Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites

被引:122
作者
Gan, JP [1 ]
Harper, TW [1 ]
Hsueh, MM [1 ]
Qu, QL [1 ]
Humphreys, WG [1 ]
机构
[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Dept Pharmaceut Candidate Optimizat, Princeton, NJ 08543 USA
关键词
D O I
10.1021/tx0496791
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A sensitive and quantitative method was developed for the estimation of reactive metabolite formation in vitro. The method utilizes reduced glutathione (GSH) labeled with a fluorescence tag as a trapping agent and fluorescent detection for quantitation. The derivatization of GSH was accomplished by reaction of oxidized glutathione (GSSG) with dansyl chloride to form dansylated GSSG. Subsequent reduction of the disulfide bond yielded dansylated GSH (dGSH). Test compounds were incubated with human liver microsomes in the presence of dGSH and NADPH, and the resulting mixtures were analyzed by HPLC coupled with a fluorescence detector and a mass spectrometer for the quantitation and mass determination of the resulting dGSH adducts. The comparative chemical reactivity of dGSH vs GSH was investigated by monitoring the reaction of each with 1-chloro-2,4-dinitrobenzene or R-(+)-pulegone after bioactivation. dGSH was found to be equivalent to GSH in chemical reactivity toward both thiol reactive molecules. dGSH did not serve as a cofactor for glutathione S-transferase (GST)mediated conjugation of 3,4-dichloronitrobenzene in incubations with either human liver S9 fractions or a recombinant GST, GSTM1-1. Reference compounds were tested in this assay, including seven compounds that have been reported to form GSH adducts along with seven drugs that are among the most prescribed in the current U.S. market and have not been reported to form GSH adducts. dGSH adducts were detected and quantitated in incubations with all seven positive reference compounds; however, there were no dGSH adducts observed with any of the widely prescribed drugs. In comparison with existing methods, this method is sensitive, quantitative, cost effective, and easy to implement.
引用
收藏
页码:896 / 903
页数:8
相关论文
共 43 条
[1]   Structure, catalytic mechanism, and evolution of the glutathione transferases [J].
Armstrong, RN .
CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (01) :2-18
[2]   Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity [J].
Boelsterli, UA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 192 (03) :307-322
[3]   SPECIFIC TARGETS OF COVALENT DRUG-PROTEIN INTERACTIONS IN HEPATOCYTES AND THEIR TOXICOLOGICAL SIGNIFICANCE IN DRUG-INDUCED LIVER-INJURY [J].
BOELSTERLI, UA .
DRUG METABOLISM REVIEWS, 1993, 25 (04) :395-451
[4]   EFFECTS OF CHEMICAL AND ENZYMIC PROBES ON MICROSOMAL COVALENT BINDING OF BROMOBENZENE AND DERIVATIVES - EVIDENCE FOR QUINONES AS REACTIVE METABOLITES [J].
BUBEN, JA ;
NARASIMHAN, N ;
HANZLIK, RP .
XENOBIOTICA, 1988, 18 (05) :501-510
[5]  
Chen WCG, 2001, ADV EXP MED BIOL, V500, P521
[6]  
Davis W, 2001, J PHARMACOL EXP THER, V296, P1
[7]  
DEKANT W, 1986, Journal of Biochemical Toxicology, V1, P57, DOI 10.1002/jbt.2570010206
[8]   Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development [J].
Evans, DC ;
Watt, AP ;
Nicoll-Griffith, DA ;
Baillie, TA .
CHEMICAL RESEARCH IN TOXICOLOGY, 2004, 17 (01) :3-16
[9]  
Gardner I, 1998, MOL PHARMACOL, V53, P991
[10]  
Graham DJ, 2003, AM J GASTROENTEROL, V98, P175